Integrating Technology and Navigation to Improve Survivorship Care in Underserved Populations
Trial Snapshot
- Phase
- Not Applicable
- Sponsor
- M.D. Anderson Cancer Center
- Enrollment
- 80
- Locations
- 1
- Primary Endpoint
- Interview Study of Breast Cancer Survivorship Programs Using Technology
Study Overview
Brief Summary
The goal of this research study to learn about breast cancer survivorship and possible ways to improve breast cancer survivorship programs using technology.
Objectives:
Objective 1: Assess breast cancer survivors on the acceptability of and preferences for the integration of patient navigation and an eHealth technology platform to improve care in the Survivorship Clinic at Lyndon B. Johnson Hospital.
Objective 2: Assess clinic stakeholders acceptability of and preferences for the integration of patient navigation and an eHealth technology platform to improve care for breast cancer patients in the Survivorship Clinic at Lyndon B. Johnson Hospital.
Detailed Description
Breast Cancer Survivors:
If patient agrees to take part in this study, they will visit the cancer survivorship clinic where the following tests and procedures will be performed:
- Patient will have a 30-60 minute interview where they will be asked about cancer-related informational needs, feelings about survivorship care plans, and preferred methods of communication with survivorship clinic staff.
- Patient will be asked about whether they would use the internet and other technologies (such as text messages for appointment reminders) as tools in breast cancer survivorship.
- Patient will use a web-based tool called HealthATM. HealthATM is a website that is designed to provide information and tools to help patients better manage their health. After 10-15 minute session with the website, patient will be asked about how easy the website was to use and other questions about their session.
- Patient will complete a short questionnaire at the end of the interview asking about personal characteristics, how involved they are in their health care, and their attitudes towards the HealthATM website. It should take about 5 minutes to complete this questionnaire.
All interviews will be audiorecorded. All audio recordings will be kept for 5 years and then destroyed. All interview data will be stored in password-protected computers and/or locked file cabinets. There will be no personal identifying information connected to patient's interview answers.
Length of Study:
Study Design
- Study Type
- Observational
- Observational Model
- Cohort
- Time Perspective
- Prospective
Eligibility Criteria
- Ages
- 18 Years to — (Adult, Older Adult)
- Sex
- All
- Accepts Healthy Volunteers
- Yes
Inclusion Criteria
- •Age 18-years or older (survivors and stakeholders)
- •Ability to read and speak English or Spanish (survivors)
- •Ability to read and speak English (stakeholders)
- •Active patient at the LBJ General Hospital Survivorship Clinic (survivors only)
- •Previous cancer diagnosis with no evidence of recurrence at 3 years or greater following initial diagnosis (survivors only)
- •Harris County Hospital District employee offering clinical or administrative support to the LBJGH Cancer Survivorship Clinic (stakeholders only)
- •Cancer survivors who are at least 6 months from diagnosis
Exclusion Criteria
- Not provided
Outcomes
Primary Outcomes
Interview Study of Breast Cancer Survivorship Programs Using Technology
Time Frame: 1 day
Breast cancer survivors and clinic staff surveys analyzed regarding acceptability of, and preferences for integration of patient navigation and an eHealth technology platform. Focus group and interview transcripts analyzed using ATLAS.ti qualitative analysis software. To analyze these data, constant comparative method used to conduct thematic analysis of transcribed data. As secondary check of breast cancer survivor data, calculation of descriptive statistics for measures administered to survivors following interview (frequencies, means, and standard deviations) including Patient Activation Measure and Systems Usability Scale.
Secondary Outcomes
No secondary outcomes reported